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The insulin-like growth factor 2 (IGF2) mRNA binding proteins (IMPs/IGF2BPs) IMP1 and
3 are regarded as oncofetal proteins, whereas the hepatic IMP2 expression in adults is
controversially discussed. The splice variant IMP2-2/p62 promotes steatohepatitis and
hepatocellular carcinoma. Aim of this study was to clarify whether IMP2 is expressed
in the adult liver and influences progression toward cirrhosis. IMP2 was expressed
at higher levels in embryonic compared to adult tissues as quantified in embryonic,
newborn, and adult C57BL/6J mouse livers and suggested by analysis of publicly
available human data. In an IMP2-2 transgenic mouse model microarray and qPCR
analyses revealed increased expression of liver progenitor cell (LPC) markers Bex1,
Prom1, Spp1, and Cdh1 indicating a de-differentiated liver cell phenotype. Induction of
these LPC markers was confirmed in human cirrhotic tissue datasets. The LPC marker
SPP1 has been described to play a major role in fibrogenesis. Thus, DNA methylation
was investigated in order to decipher the regulatory mechanism of Spp1 induction.
In IMP2-2 transgenic mouse livers single CpG sites were differentially methylated, as
quantified by amplicon sequencing, whereas human HCC samples of a human publicly
available dataset showed promoter hypomethylation. In order to study the impact of IMP2
on fibrogenesis in the context of steatohepatitis wild-type or IMP2-2 transgenic mice
were fed either a methionine-choline deficient (MCD) or a control diet for 2–12 weeks.
Czepukojc et al. IMP2 Promotes Ductular Reaction
MCD-fed IMP2-2 transgenic mice showed a higher incidence of ductular reaction
(DR), accompanied by hepatic stellate cell activation, extracellular matrix (ECM)
deposition, and induction of the LPC markers Spp1, Cdh1, and Afp suggesting the
occurrence of de-differentiated cells in transgenic livers. In human cirrhotic samples
IMP2 overexpression correlated with LPC marker and ECM component expression.
Progression of liver disease was induced by combined MCD and diethylnitrosamine
(DEN) treatment. Combined MCD-DEN treatment resulted in shorter survival of IMP2-2
transgenic compared to wild-type mice. Only IMP2-2 transgenic livers progressed to
cirrhosis, which was accompanied by strong DR. In conclusion, IMP2 is an oncofetal
protein in the liver that promotes DR characterized by de-differentiated cells toward
steatohepatitis-associated cirrhosis development with poor survival.
Keywords: liver cancer, stem cell, de-differentiation, oval cell, HCC, fibrosis
INTRODUCTION
The family of insulin-like growth factor (IGF) 2 mRNA binding
proteins (IMPs/IGF2BPs), namely IMP1 and IMP3, have been
described as oncofetal proteins. However, whether IMP2 is
an oncofetal protein or not remains a matter of debate (1–
3). IMP2 has been described to be essential for preserving
glioblastoma cancer stem cells (4). It is known that the
occurrence of hepatic stem cells, i.e., liver progenitor cells
(LPCs) worsens prognosis in liver disease. Noteworthy, more
than half of the earliest hepatic premalignant lesions consist
of LPCs and intermediate hepatocytes (5). Human and murine
HCCs show LPC gene signatures and contain LPC fractions
(6). Concordantly, p53-deficient or H-RAS/SV40LT-transduced
isolated LPCs can generate HCC in xenotransplant models
(7, 8). In cholangiocarcinoma aberrant expression of stem cell
markers suggest LPCs to be the cell of origin in tumors (9).
Interestingly, mixed types of cholangiocarcinoma and HCC
have been described in the literature, which are thought to
derive from transformed progenitor cells (10). Thus, it has
been suggested that LPCs may be precursor cells for malignant
transformation (11). However, recent evidence using lineage
tracing in different mouse models demonstrates that HCC rather
seem to develop from dedifferentiated hepatocytes than from
LPCs (12, 13).
Still, the majority of non-malignant chronic liver diseases
are characterized by LPC activation (5). In ductular reaction
(DR), activated LPCs organize in strings (14) and finally
lead to increased numbers of bile ducts that form a denser
mesh around portal vein branches (15) or even infiltrate into
the lobular parenchyme (16). Interestingly, the degree of DR
correlates with disease progression (17). DR comparable to
the one found in human non-alcoholic steatohepatitis (NASH)
can be induced by a methionine-choline deficient diet (MCD)
showing high similarity with NASH samples with advanced
fibrosis (18).
In this study, we confirm the oncofetal appearance of IMP2
in murine and human liver. Employing transgenic mice we show
that IMP2-2 is able to promoteDR resulting in cirrhosis and short
survival in the steatohepatitis model. Human gene expression
data further support the association of IMP2 with marker genes
of undifferentiated or dedifferentiating cells in liver disease.
METHODS
Animals
Liver tissue from C57BL/6J mice at embryonic day E12.5 (n= 5),
newborns (P0, n= 8), and at the age of 2, 10, and 85 weeks (each n
= 6) were obtained. Publicly available RNA sequencing data sets
from murine (PRJNA66167) and human (PRJNA280600) fetal
and adult liver (19) were analyzed.
Wildtype (wt) and IMP2-2 transgenic (tg) mice were
generated as previously described (20). At the age of 5 weeks,
livers were examined by qPCR (wt: n = 13, tg: n = 13) and
microarray analysis (wt: n = 10, tg: n = 10). In order to
induce NASH, wt and IMP2-2 tg mice were randomly divided
into experimental groups at the age of 3 weeks and were
fed either a methionine choline deficient diet (MCD, #960439,
MP Biomedicals, Germany) or a MCD diet supplemented with
choline bitartrate (2 g/kg) and DL-methionine (3 g/kg) (MCS,
#960441, MP Biomedicals, Germany) for 2, 4, or 12 weeks (21) (2
weeks: MCS: wt: 5 females and 5 males; tg: 6 females and 4 males;
MCD: wt: 5 females and 7 males; tg: 7 females and 5 males; 4
weeks: MCS: wt: 5 females and 5 males; tg: 5 females and 5 males;
MCD: wt: 6 females and 6 males; tg: 6 females and 6 males; 12
weeks: MCS: wt: 5 females and 4 males; tg: 6 females and 5 males;
MCD: wt: 5 females and 5 males; tg: 5 females and 4 males). For
the combined treatment withMCD and the genotoxic carcinogen
diethylnitrosamine (DEN) (22) two different treatment schemes
were used: one set of 3 week old wt (n = 28; females: n = 14,
males: n = 14) and IMP2-2 tg (n = 24; females: n = 9, males: n
= 15) mice received an MCD diet and 4 weeks after the onset of
MCD feeding one injection of DEN (5mg/kg BW i.p.). Mice were
sacrificed at the age of 15 weeks or before when at least one of
the stopping criterions (behavioral disorder, loss of weight>50%,
abnormal water or feed uptake, matt coat, or an impairment of
the locomotor system) was met. The other set of 2 week old wt
(n = 10) and IMP2-2 tg (n = 13) mice received a single injection
of diethylnitrosamine (DEN, 5 mg/kg BW i.p.) and were fed a
MCD diet at the age of 8 weeks (wt: n = 10, females: n = 5,
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males: n = 5; tg: n = 13, females: n = 7, males: n = 6). Mice
were sacrificed at the age of 29 weeks. Mice were housed in a
12/12 h light/dark cycle under constant conditions (temperature:
22◦C ± 2◦C; relative humidity: 55% ± 10%) with an enriched
environment and food and water ad libitum. Mice were sacrifized
by cervical dislocation or decapitation (embros, newborns) and
whole blood samples were taken and liver was excised. Two thirds
of the liver was flash-frozen in liquid nitrogen and stored at
−80◦C for further analysis. One third of the liver containing half
of the left lateral lobe and half of the medial lobe in the same
cassette was fixed in 4% PBS-buffered formalin for 24 h. After
fixation samples were dehydrated and embedded in paraffin.
Whole blood samples were incubated for 1 h at room
temperature to allow agglutination of red blood cells and
subsequently centrifuged for 10min at 13,500 × g at 4◦C. The
supernatant was transferred into a fresh tube, diluted 1:3 with
0.9% NaCl, and stored at −80◦C until measurement. Serum
alanine aminotransferase (ALT), aspartate aminotransferase
(AST), glucose, triglycerides (TG), cholesterol, and high density
lipoprotein (HDL) levels were determined by a PPE Modular
analyzer using Roche R© reagents at a constant temperature of
37◦C (Roche Diagnostics, Mannheim, Germany). Measurements
were performed at the “Zentrallabor des Universitätsklinikums
des Saarlandes” (Homburg, Germany).
RNA Isolation, Reverse Transcription, and
qPCR
In general, RNA isolation and qPCR were performed as
previously described (23–25). Total RNA was extracted using
Qiazol lysis reagent (Qiagen, Germany) according to the
manufacturer’s instructions and treated with DNase I (Ambion,
Germany) to remove residual DNA. cDNA was synthesized
using the high-capacity cDNA reverse transcription kit (Applied
Biosystems) according to the manufacturer’s protocol using
random primers. qPCR was performed using 5x HOT FIREPol R©
EvaGreen R© qPCR Mix Plus (Solis BioDyne, Estonia) according
to the manufacturer’s instructions and the CFX96 TouchTM
Real-Time PCR Detection System (Bio-Rad, Germany).
For absolute quantification PCR products were cloned into
pGEMTeasy (Promega, Germany) and respective dilutions were
run alongside the samples to generate a standard curve. All
samples and standards were analyzed in triplicate using the
following PCR conditions: 95◦C for 15min, followed by 39 cycles
of 20 s at 94◦C, 20 s at the primer-specific annealing temperature,
and 20 s at 72◦C. The relative expression was normalized to
18S or Ppia mRNA values depending on their stability. In sum,
three different housekeeping genes (18s, Ppia/Cyclophilin, and
Csnk2a2) were tested using the GeNorm tool and Normfinder
(26, 27). Real-time quantitative PCR (qRT-PCR) was performed
using the following primer pairs: Rn18S 5′-AGGTCTGTGATG
CCCTTA GA-3′ and 5′-GAATGGGGTTCAACGGGT TA-3′;
Ppia 5′-GGCCGATGACGAGCCC-3′ and 5′-TGTCTTTG
GAACTTTGTCTGC-3′; Afp 5′-CCAGGAAGTCTGTTTCA
CAGAAG-3′ and 5′-CAAAAGGCTCACACCAAAGAG-3′;
Krt19 5′-AGCGTGATCAGCGGTTTTG-3′ and 5′-CCTGGT
TCTGGCGCTCTATG-3′; Sox9 5′-CCAGCAAGAACAAGCC
ACAC-3′ and 5′-CTTGCCCAGAGTCTTGCTGA-3′; Spp1
5′-CCGAGGTGATAGCTTGGCTTAT-3′ and 5′-GACTCCT
TAGACTCACCGCTC-3′; Cdh1 5′-CTTTTCGGAAGACTCCC
GATT-3′ and 5′-GCTTTAGATGCCGCTTCACTGT-3′; Imp2
5′-CTGATCCCAGGGCTAAACCTC-3′ and 5′-AAGGGGT
GATAGGGAGGACTG-3′; Dlk1 5′-ACTTGCGTGGACCTGGA
GAA-3′ and 5′-CTGTTGGTTGCGGCTACGAT-3′.
Western Blot Analysis
Western blots were performed as previously described (20).
Histology
Histochemistry and immunohistochemistry were performed
as previously described (21, 25, 28). Paraffin-embedded liver
sections were stained with hematoxylin-eosin (HE) and Sirius
Red. Immunohistochemical (IHC) KRT19 and AFP detection
was achieved using Dako EnVision+ System-HRP Labeled
Polymer Anti Rabbit (#K4003, DAKO, USA) with anti-KRT19
antibody (1:1,000, #52625, abcam, UK), anti-DLK1 (1:1,000,
#21682, abcam, UK) or anti-AFP antibody (1:1,000, #46799,
abcam, UK). Epitopes were demasked with citrate buffer (10mM,
pH 6.0) in a waterbath at 95◦C for 45min. For Laminin detection
epitopes were demasked by proteinase K (20µg/ml in TE buffer)
incubation for 15min at 37◦C in a waterbath. Anti-laminin
antibody (1:200, #L9393, Sigma) was incubated for 1 h at room
temperature followed by incubation with anti-rabbit Envision
(Dako, Germany) for 20min at room temperature and DAB
staining. Hyaluronic acid was detected by staining with a biotin-
labeled hyaluronic acid binding protein (1:100, #AMS.HKD-
BC41, Amsbio) for 1 h at room temperature and detection by
Streptavidin-HRP (#K3954, Dako, Germany) for 20min at room
temperature and DAB staining. Stainings were evaluated for
steatosis, inflammation, DR, and fibrosis by two independent,
blinded investigators with the scoring system shown in Table 1.
Fibrosis scoring was assessed according to Kleiner et al. (29).
Steatosis scoring was performed according to Simon et al. (21).
Scoring system for ductular reaction was based on Chen et al.
(30). We adapted the scoring of the latter study by including two
different cirrhosis scores: 3= cirrhosis with few and 4= cirrhosis
withmanyDR (seeTable 1). In order to avoid high complexity we
additionally combined score 1 and 2 from Chen et al. into score
1 in the current study.
Cell Culture
Huh7 cells were cultured in RPMI-1640 medium supplemented
with fetal calf serum, penicillin/streptomycin and glutamine
(Sigma-Aldrich, Taufkirchen, Germany) at 37◦C and
5% CO2. Cells were treated with decitabine/5-aza-2′-
deoxycytidine (#A3656, Sigma-Aldrich) over 3 days. The
DNA-methyltransferase inhibitor was freshly added daily.
Authentication of cell lines was confirmed by DSMZ.
Amplicon Sequencing Analysis
Ten percent of each bisulfite-treated sample were used as
template in a 30 µL PCR mix: buffer BD (80mM Tris-HCL,
20mM (NH4)2SO4), 2.5mM MgCl2, 0.2mM of each dNTP,
200 nm each of the forward and reverse primers (sequences
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see Table 2) with universal Illumina adapters attached at the 5′
end, and 3U HotFirePol (Solis BioDyne). For each DNA lot,
PCR reactions were performed in triplicates starting with 15min
denaturation at 95◦C followed by 42 cycles of 95◦C for 60 s,
annealing for 120 s (seeTable 2), 72◦C for 120 s, and a final 5-min
extension step at 72◦C. About 5 µL PCR reaction were loaded on
1.2% agarose gels. Remaining 25 µL of the PCR reaction were
purified with Agencourt Ampure XP beads (Beckman Coulter,
Krefeld, Germany), diluted, pooled, and sequenced (Illumina
v3 chemistry, 2 × 300 bp paired end) on Illumina MiSeq
following the manufacturer’s instructions aiming at 10,000 reads
per amplicon and sample. Alignments and evaluation were done
TABLE 1 | Scoring system for histological analyses.
Scoring system Assessed by
Ductular
reaction
Score 0
Score 1
Score 2
Score 3
Score 4
None
Rare-few (1–6 DR per field)
Many (>6 DR per field)
Cirrhosis with few DR
Cirrhosis with many DR
HE and Krt19 IHC
Fibrosis Score 0
Score 1
Score 2
Score 3
Score 4
None
Perisinusoidal or periportal
Perisinusoidal and
portal/periportal and/or
septal
Bridging fibrosis
portal/periportal and septal
Cirrhosis (complete
surrounding of liver cell
nodules by fibrous septa)
Sirius red
Steatosis Score 0
Score 1
Score 2
Score 3
Score 4
0%
<5%
>5–20%
>20%
>50%
HE
Inflammation Portal
Score 0
Score 1
Lobular
Score 0
score 1
Score 2
score 3
None to minimal;
greater than minimal;
None
<2/200x
2–4/200x
>4/200x
HE
with the BiQ Analyzer HT program filtering all reads with more
than 10% unrecognized CpG sites (31). Primers used for PCR for
amplicon sequencing of murine Spp1 can be found in Table 2.
Microarray Analysis
For Affymetrix gene expression microarray analysis RNA was
extracted from snap frozen liver tissue of 5 week-old IMP2-
2 tg mice (n = 10) and corresponding controls (n = 10),
as described in Godoy et al. (32). The Gene Chip IVT
Labeling kit (Affymetrix, High Wycombe, UK) was used to
generate biotinylated cRNA. Purification and fragmentation was
performed according to Affymetrix’s protocol. Hybridization to
Mouse Genome 430 2.0 Affymetrix GeneChips (Santa Clara,
CA, USA) was conducted for 16 h at 45◦C according to the
manufacturer’s instructions. Microarrays were scanned with an
Affymetrix scanner controlled by Affymetrix Microarray Suite
software. Robust Multi-array Average (RMA) algorithm (33)
was used for normalization of the gene expression array data
and the R package limma (34) was used for calculation of
differential gene expression. Adjustment for multiple testing
was conducted with the method of Benjamini and Hochberg
(FDR: false discovery rate) (35). Data are available on Gene
Omnibus (GEO-ID: GSE130999).
Public Gene Omnibus (GEO) and TCGA
Datasets
GEO dataset GSE14323 and the liver hepatocellular carcinoma
dataset from TCGA were analyzed as described previously
(21, 25, 28, 36). The GEO dataset GSE14323 was analyzed for
differential gene expression in human tissue samples of normal
liver (n = 19), pre-malignant cirrhosis (n = 41), cirrhosis
of HCC-livers (n = 17), and HCC (n = 48) as described
previously (21, 25, 28, 36). TCGA liver cancer samples (n =
159) were analyzed for promoter methylation of SPP1. Statistical
significance was analyzed in the R-cran statistical environment
by the Kolmogorov–Smirnov test followed by FDR-correction
with the Benjamini-Hochberg method Q = 0.05, and up to m
= 10 (35). Pearson correlation was applied to detect correlations
between genes of interest.
TABLE 2 | Primers used for PCR for amplicon sequencing of murine Spp1.
Ampli-con ID Genomic position (mm10) Primer forward (5′-3′) Primer reverse (5′-3′) Annealing temperature (◦C)
Spp1_1 chr5:104434413-104434742 GGTTATTGTGTGGTTTGTATAAAGAGT CACATAAATACACAATTTAATTCTCTCAA 54
Spp1_2 chr5:104434987-104435392 TAAAATTAGAGGAGGAAGTGTAGGAGT AAATTTATTTTAACTTCTACATCCAACTA 54
Spp1_3 chr5:104436033-104436270 TTTTTGTAGAAAGTATTTTTATGGTAGTT TACATCTCAAAAAAAATTTCAATAAA 54
Spp1_4 chr5:104436350-104436768 TTGTGTTTTATAAAATATGTTGTAGGAT AAAAAAATCTATTTATTAAAAACAATAAC 54
Spp1_5 chr5:104437141-104437598 ATTTTGTGTTTGGATAAAAAGGTATAT AAAACTCTATAAACCATAACCTTAACATA 54
Spp1_6 chr5:104437693-104438080 GGTGTTTGATTTATTTTAGAAGTAGAATT TATCCATTAATCCTCTAAACACTCAC 54
Spp1_7 chr5:104439171-104439512 AAGATTTTGAAATTTAATTAAAATGTTTT AACCTCAATCCATAAACCAAACTAT 54
Spp1_8 chr5:104439713-104440076 TGTGTGTGATGTTTTTTTAATTTTATT AATCAACTTCATATCAATCATTTCTAA 56
Spp1_9 chr5:104440214-104440610 TTGTTTTTGATTTAGTATTTTGATGTT CCTCAAAAAATAAACTCTCTAATTCATA 60
Spp1_10 chr5:104440722-104441072 TGGATATATGTATGTAGAGAAAGAGAGGT ATAATTAACACCACCAAACTCCTTACA 60
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High-Resolution Ultrasound
Mice were anesthesized with isoflurane and put on a heated
stage in supine position. Chemical depilation (Nair hair removal
cream) was done to prevent air trapped in the fur from interfering
with ultrasound coupling into the animal. After removing the
liver, ultrasound coupling gel (Aquasonic 100, Parker, Fairfield,
NJ, USA) was circumferentially applied to the ex situ liver, to
distinguish between the stage and the ex situ liver. Imaging was
performed by means of a Vevo 770 high-resolution ultrasound
system (VisualSonics, Toronto, ON, Canada) and a real-time
microvisualization 704 Scanhead (VisualSonics) with a center
frequency of 40 MHz and a focal depth of 6mm. For 3D
imaging the scanhead, driven by a linear motor, scanned first
the in situ and then the ex situ liver. The technique yielded
two-dimensional (2D) images at parallel and uniformly spaced
100µm steps. The 2D image planes enabled rapid 3D image
reconstruction, displaying a dynamic cube view format, as
previously described (37).
Statistical Analysis
OriginPro 2018G software (OriginLab Corporation) was used for
illustration and statistical analyses. Results are shown as means
± SEM or box plots with 25th/75th percentile boxes, geometric
medians (line), means (square). Statistical significance was
FIGURE 1 | Expression of IMP2, IGF2, and H19 in embryonic and adult livers. (A) IMP2, IGF2, and H19 gene expression from publicly available RNA sequencing data
sets of murine (PRJNA66167) and human (PRJNA280600) fetal liver compared to adults. Data are expressed as x-fold from 8 week-old murine or adult human tissues
indicated by dashed lines, respectively. RPKM: Reads per kilobase transcript per million reads. (B,E,F) qPCR analysis of Imp2 (B), Igf2 (E), and H19 (F) in livers of
fetal (E12.5; n = 5), newborns (P0, n = 8), 2, 10, and 85 week-old (each n = 6) mice. Expression levels were normalized to Ppia/Cyclophilin as housekeeping gene.
(C,D) Western blot analysis of IMP2 protein expression in fetal, newborn, young, and adult mouse livers. Representative image of Western blot (C) and densitometric
quantification of IMP2 levels normalized to tubulin (D) are shown (E12.5: n = 4; P0: n = 8; 2 and 10 week: n = 4; 85 week: n = 6). P-values were calculated by
Mann-Whitney U-test.
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determined by Mann-Whitney U-test or t-test where applicable.
Chi2 test was used for categorical data. Statistics of Kaplan-Meier
survival analysis was performed by log rank test.
RESULTS
Resource Identification Initiative
Analysis of publicly available gene expression data showed high
IMP2 expression in fetal mouse and human livers compared
to the respective adult tissue (Figure 1A). Embryonic markers,
such as IGF2 and H19, were highly expressed in fetal livers
(Figure 1A). The low expression of Imp2 in adult and high
expression in fetal liver was confirmed by qPCR analysis of a
time course of fetal, neonatal, young, and old mice (Figure 1B).
Expression of IMP2 protein matched that of its transcript
(Figures 1C,D). Further, the high levels of H19 and Igf2 in
embryonic livers and low levels in adult livers were confirmed
in the same time course (Figures 1E,F). Interestingly, H19
expression was highest in livers of newborn and young animals
(Figure 1F).
These data showed the highest IMP2 expression in embryonic
liver. We therefore hypothesized that IMP2 in adult liver
may represent a marker of immaturity or dedifferentiation
and aimed at investigating the impact of IMP2 expression
on hepatic progenitor cell features. Since peritumoral DR
correlates with fibrosis stage (38) we first analyzed the
expression of IMP2 and common progenitor cell marker
genes in gene expression data sets from human cirrhotic
tissue (Figure 2A). Human cirrhotic and cirrhosis-associated
HCC tissues showed an increase of IMP2 expression and of
the progenitor cell markers SOX9, SPP1/osteopontin, CDH1/E-
cadherin, AFP, PROM1/CD133, BEX1, EPCAM (Figure 2A). We
next investigated the consequences of overexpressing IMP2-
2 in the liver. Array analysis of IMP2-2 tg mice revealed an
upregulation of the murine homologs LPC marker genes except
for Sox9 (Figure 2B). Upregulation was confirmed by qPCR for
some of the genes, i.e., Spp1, Afp, and Cdh1 (Figure 2C). Krt19,
which was not on the array platform and Sox9, both markers of
DR, were not upregulated (Figure 2C).
IMP2-2 tg mice have been shown to develop steatosis without
any sign of liver damage (20). Due to the increased levels of
markers of de-differentiation, IMP2-2 tg mice were challenged
with an MCD diet, which is known to induce DR within 8
weeks in the setting of steatohepatitis (18). In IMP2-2 tg mice
DR was observed in 25% of the IMP2-2 tg animals fed the
MCD diet already after 2 weeks (Figure 3A). On the control diet
(MCS) none of the IMP2-2 tg mice of the 2 week time point
and only 10% of the IMP2-2 tg mice of the 4 week timepoint
developed DR (Figure 3A). More pronounced DR was observed
in the IMP2-2 tg livers after 4 weeks of MCD feeding as shown
by immunohistochemistry of KRT19 (Figures 3A,B). After 12
weeks of MCD diet more severe DR was observed in wt as well
as in IMP2-2 tg mice with no statistically significant difference
between both genotypes (data not shown), but fibrosis was still
increased in the transgenics (Figure 3C). Interestingly, the IMP2-
2 transgene was not only expressed in hepatocytes but also
DR cells under MCD feeding (Figure 4A). After 4 weeks DR
in IMP2-2 tg mice was characterized by increased expression
of the cholangiocyte and progenitor cell markers Krt19 and
Sox9 (Figure 4B). The progenitor cell marker genes Spp1 and
Afp were induced to a higher extent in MCD-fed IMP2-2 tg
mice compared to wt livers (Figure 4B). Cdh1 tended to be
increased in IMP2-2 tg livers on MCD diet (Figure 4B). Igf2
levels were especially increased in female mice (data not shown),
while the increase of the other progenitor cell markers in tg
mice were sex independent. Since SPP1 was shown to activate
hepatic stellate cells (HSCs), which can then produce extracellular
matrix (ECM) components, we investigated α-smooth muscle
actin (α-SMA) and Col1a1 levels as a measure of differentiation
to myofibroblasts in MCD-fed mice and observed increased
Col1a1 mRNA levels and α-SMA positive cells in IMP2-2 tg
animals (Figures 4B,C). Myofibroblasts are known to produce
ECM components. Thus, immunohistochemistry was performed
to investigate the deposition of ECM components in the areas
of DR of IMP2-2 tg livers. DR cells were surrounded by the
ECM components laminin and hyaluronic acid (Figure 4D).
In human cirrhotic tissue SPP1 was upregulated (Figure 2A)
and strongly correlated with IMP2 expression (R2 = 0.42 p
= 0.006 in cirrhosis). Further correlation analysis revealed a
strong association of IMP2 and SPP1with ECM components, i.e.,
laminin b (LAMB), laminin c (LAMC), hyaluronic acid receptor
CD44, and fibrillin 1 (FBN1) (Figure 4E).
SPP1 is known to promote fibrogenesis (39) thereby linking
liver progenitor cell activation to fibrotic changes (40). Since
Spp1 expression was reported to be regulated by altered
DNA methylation in murine CCl4-induced fibrosis (41), we
hypothesized that SPP1 hypomethylation might cause SPP1
induction in HCC. Therefore, we measured SPP1 expression
after incubation of HCC cells with the demethylating agent
decitabine as well as SPP1 DNA methylation in human samples.
In fact, decitabine treatment in in vitro cultivated HCC cells
strongly induced SPP1 expression (Figure 5A). In silico analysis
of the human TCGA HCC dataset revealed SPP1 promoter
hypomethylation in HCC patient tissues compared to normal
liver tissues (Figure 5B). In order to test whether elevated Spp1
expression in untreated IMP2-2 tg mice is due to epigenetic
changes we performed amplicon-based local deep sequencing
covering the whole Spp1 gene with 60 single CpG positions in
IMP2-2 tg and wt mice (42). Although Spp1 expression was
significantly elevated in untreated IMP2-2 tg mice (Figure 5C),
only minor methylation changes in single CpG sites of Spp1 were
observed (Figure 5D). CpG#1 was significantly hypomethylated
in IMP2-2 tg compared to wt mice (Figure 5D).
Since DR associates with fibrosis, it is associated with poor
prognosis in liver disease (43). Therefore, we analyzed whether
additional administration of the genotoxic carcinogen DEN
caused more severe fibrosis in IMP2-2 tg livers. Two different
treatment schemes were used with DEN injection before or after
the onset of MCD feeding (Figures 6A, 7A).
In the DEN-MCD treated animals (Figure 6A) high ALT and
AST levels were found (Table 3). No difference between the
genotypes regarding AST, ALT, triglycerides, cholesterol, HDL,
and glucose were observed (Table 3). Steatosis ranged from
score 2–4 in both genotypes and also inflammation was rather
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FIGURE 2 | IMP2-2 induces stem cell marker expression. (A) Expression analysis of IMP2, SOX9, SPP1, CDH1, AFP, PROM1, BEX1, EPCAM in human samples of
normal liver tissue (n = 19), cirrhotic tissue (without HCC; n = 41), cirrhotic tissue of HCC-livers (with HCC; n = 17), and HCC tissue (n = 48) (GSE14323). The table
shows expression values as x-fold of healthy (n = 19) liver samples. P-values were generated by comparison to healthy tissue (Mann Whitney U-test or Welch’s t-test,
FDR-corrected by Benjamini-Hochberg method). (B) Gene expression of Sox9, Spp1, Cdh1, Afp, Prom1, Bex1, and Epcam in 5 week-old IMP2-2 transgenic animals
(tg) determined by micro array analysis (n = 10 per genotype). Data are expressed as x-fold of wildtype (wt) animals (indicated as dashed line). FDR adjusted p-values
are shown. For Afp median value of five different probes is shown (probe 1: x-fold = 17.62, adj. p = 0.002; probe 2: x-fold = 5.35, adj. p = 0.008; probe 3: x-fold =
4.52, adj. p = 0.005; probe 4: x-fold = 1.38, adj. p = 0.009; probe 5: x-fold = 0.95, adj. p = 0.35). (C) Krt19, Sox9, Spp1, Cdh1, and Afp mRNA expression of
IMP2-2 tg mice (n = 13) normalized to the values of wt mice (n = 13). P-values were calculated in comparison with wt animals (Welch’s t-test, FDR-corrected by
Benjamini-Hochberg method).
advanced in both genotypes (Figure 6B). Ultrasound analysis
followed by macroscopic analysis exhibited the presence of
cirrhotic nodules in IMP2-2 tg livers (nodule size>0.5 mm: wt: n
= 2 with and n = 8 without nodules, tg: n = 10 with and n = 1
without nodules, p = 0.0019 tg compared to wt; Figures 6C,D).
Sirius red staining confirmed fibrotic changes leading to cirrhosis
only in the IMP2-2 tg livers (Figure 6E) with a varying extent
of DR in the transgenics, while wt livers only showed weak DR
(Figure 6F).
The MCD-DEN model (Figure 7A) revealed no difference
in serum parameters (AST, ALT, triglycerides, cholesterin, HDL,
and glucose), steatosis, and inflammation between the genotypes
(Figure 7A; Table 3). In line with the other treatment scheme
no difference between the genotypes was observed regarding
steatosis and inflammation (Figure 7B), but cirrhosis was only
present in the IMP2-2 tg livers (Figure 7C) with only few
macroscopically visible nodules with no significant difference
between wt and tg regarding occurrence of nodules. In the
MCD-DEN set cirrhosis was linked to a significantly shorter
survival time of the transgenic animals compared to wt controls
(p = 0.0056, Figure 7D). The MCD-DEN treatment group
contained livers showing cirrhosis accompanied by strong DR
(Figure 7E). Investigation of two progenitor cell markers, DLK1
and AFP, revealed a significant upregulation of Afp mRNA and
protein levels in the IMP2-2 tg animals in the MCD-DEN model
(Supplementary Figures 1, 2).
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FIGURE 3 | IMP2-2 expression accelerates DR in the MCD model. (A) Histological scoring of DR in IMP2-2 transgenic (tg) and wildtype (wt) mice, which were fed
either a methionine-choline deficient (MCD) diet or a methionine-choline supplemented (MCS) control diet for 2 and 4 weeks (2 weeks: MCS: n = 10 per genotype,
MCD: n = 12 per genotype; 4 weeks: n = 10 per genotype, MCD: n = 12 per genotype). The p-value was calculated by chi-square test. (B) Representative images of
HE and KRT19 stainings from wt and tg mice on MCS or MCD diet for 4 weeks. For tg mice representative images of DR score 1 and DR score 2 are shown (scale
bars: 100µm). (C) Histological scoring of Sirius red stained sections for fibrosis of wt and tg mice, which were fed either a methionine-choline deficient (MCD) diet or a
methionine-choline supplemented (MCS) control diet for 12 weeks (MCS: n = 9–11 per genotype, MCD: n = 9–10 per genotype).
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FIGURE 4 | IMP2-2 expression correlates with the expression of extracellular matrix components. (A) Representative images of IMP2 staining in tg mice on MCS or
MCD diet for 4 weeks (scale bars: 100µm). (B) Krt19, Sox9, Spp1, Cdh1, Afp, Col1a1 mRNA expression levels of 4 weeks MCD-fed IMP2-2 tg mice (n = 12), shown
as x-fold of wild-types (n = 12; indicated by dashed line). 18S was used as a housekeeping gene. Statistical significance compared to wt was determined by
Mann-Whitney U-test or Welch’s t-test. (C) Representative immunohistochemical staining for α-SMA in wt and tg mice fed a MCD or a MCS control diet for 4 weeks
(MCS: n = 10 per genotype, MCD: n = 12 per genotype; scale bars: 50µm). (D) Representative image of an area of DR stained for laminin (upper panel) and
hyaluronic acid (lower panel) in wt and tg mice fed a MCD diet for 4 weeks (n = 12 per genotype; scale bars: 100µm). (E) Heatmap shows expression of LAMB1,
LAMC1, CD44 and FBN1 in human samples of normal liver tissue (n = 19), cirrhotic tissue (n = 41), cirrhotic tissue of HCC-livers (n = 17), and HCC tissue (n = 48)
(GSE14323). The table shows a correlation analysis of IMP2 and SPP1 with LAMB1, LAMC1, CD44, and FBN1 in human samples of cirrhotic tissue (n = 41) and
cirrhotic tissue of HCC-livers (n = 17) (GSE14323). The correlation coefficient was calculated by Pearson correlation.
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FIGURE 5 | Differential SPP1 methylation in human HCC and IMP2-2 tg mice. (A) SPP1 expression in Huh7 cells treated with either 0.25 or 0.5µM decitabine for
72 h quantified by qPCR. Decitabine-containing medium was changed every 24 h. (B) SPP1 promoter methylation in the TCGA liver cancer set in tumor vs.
non-tumorous tissues. (C) Spp1 expression in IMP2-2 tg and wt mice on normal chow quantified by qPCR. 18S was used as housekeeping gene. (D) Methylation of
CpG sites within the Spp1 gene in IMP2-2 tg (orange) vs. wt (blue) mice analyzed by amplicon sequencing. CpG sites are plotted along the x-axis according to their
location in the gene, i.e., in the promoter region, introns [intron1 (i1), intron2/intron3, intron4 (i4), intron5 (i5), and intron6 (i6)], and exons (exon2 (e2), exon4 (e4), exon6,
exon7). *p < 0.05; **p < 0.01.
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FIGURE 6 | IMP2-2 triggers cirrhotic changes in the DEN-MCD model. (A) Treatment scheme of the DEN/MCD model. Administration of diethylnitrosamine (DEN) 6
weeks before the onset of MCD feeding (DEN-MCD). (B) Representative images of HE (left) and histological scorings for steatosis, lobular and portal inflammation of
wt and tg mice treated with DEN-MCD. Arrows indicate inflammatory foci (scale bars: 50µm). (C,D) Representative images of high-resolution ultrasound (C) and
macroscopic view (D) of a liver of DEN-MCD mice. (C) High-resolution ultrasound imaging of an in situ (upper image) and ex situ (lower image) liver. Scale bars 0.9mm
(upper image), 1.2mm (lower image). (E) Representative images of Sirius Red staining (left) and histological scoring for fibrosis (right) of wt and tg mice treated with
DEN-MCD (wt: n = 10, tg: n = 13) (wt: score 2; tg: score 4; scale bars: 50µm). (F) Histological scoring of KRT19 staining for DR (right) of wt and tg mice treated with
DEN-MCD (wt: n = 10, tg: n = 13).
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FIGURE 7 | Transgenic expression of IMP2-2 leads to shorter survival in the MCD-DEN model. (A) Treatment scheme of the MCD/DEN model. Administration of DEN
5 weeks after the onset of MCD feeding (MCD-DEN). (B) Representative images of HE (left) and histological scorings for steatosis, lobular and portal inflammation of
wt and tg mice treated with MCD-DEN (wt: n = 28, tg: n = 24). Arrows indicate inflammatory foci (scale bars: 50µm). (C) Representative images of Sirius Red
staining (left) and histological scoring for fibrosis (right) of wt and tg mice treated with MCD-DEN (wt: n = 28, tg: n = 24) (wt: score 1; tg: score 3; scale bars: 50µm).
(D) Kaplan-Meier survival plot referring to wt and tg animals treated with MCD-DEN (wt: n = 28, tg: n = 24). (E) Representative images of KRT19 staining (left) and
histological scoring for DR (right) of wt and tg mice treated with MCD-DEN (wt: n = 28, tg: n = 24) (scale bars: 200µm).
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TABLE 3 | Serum parameters in DEN-MCD and MCD-DEN treated mice.
DEN-MCD MCD-DEN
wt tg wt tg
ALT [U/l] 409.7 ± 129.6 428.7 ± 151.6 80.6 ± 15.5 60.3 ± 13.5
AST [U/l] 3,550.9 ± 1,122.9 2,580.3 ± 912.3 2,901.1 ± 558.3 2,970.6 ± 664.2
Triglycerides [mg/dl] 96.2 ± 30.4 82.4 ± 29.1 127.5 ± 24.5 131.2 ± 29.3
Cholesterol [mg/dl] 35.0 ± 11.1 33.0 ± 11.7 48.3 ± 9.3 47.9 ± 10.7
HDL [mg/dl] 17.6 ± 5.6 18.4 ± 5.8 6.7 ± 1.3 5.4 ± 1.2
Glucose [mg/dl] 55.6 ± 17.6 57.3 ± 20.2 40.1 ± 7.7 44.1 ± 9.8
Means ± SEM are shown.
DISCUSSION
IMPs were originally identified and characterized as fetal proteins
(44). Although IMP2 was first described as an oncofetal protein
(3), IMP2 mRNA was suggested to be ubiquitously expressed
in adult tissue (1). However, our data clearly show that IMP2
RNA and protein is expressed in fetal but not in adult
human and mouse liver. IMP2 has been described to be re-
expressed in liver cancer (45) and to preserve glioblastoma
stem cells (4) underlining its oncofetal character. Moreover,
IMP2 is more abundant than IMP1 and IMP3 in most
cancer types and promotes an undifferentiated character of
HCC (28).
Due to this oncofetal expression in liver we hypothesized
that IMP2-2 might affect liver pathogenesis related to a de-
differentiated cell phenotype.We show that IMP2-2 tg livers were
more susceptible to DR provoked by an MCD diet. In untreated
livers expression of the IMP2-2 transgene did not result in DR but
caused elevated expression of progenitor cell markers.
In untreated livers of IMP2-2 tg mice a complex picture was
obtained, characterized by the upregulated biliary/progenitor cell
markers (Spp1), fetal hepatocytic marker (Afp), and classical
stem/progenitor cell markers (Cdh1, Prom1, Bex1, and Epcam).
Challenging these mice with the MCD diet resulted in DR
and additional upregulation of biliary/progenitor cell markers
(Krt19 and Sox9). In general, DR, which mostly constitutes
of cells of immature biliary or hepatobiliary phenotype, are
diverse in their cellular components (46). Although SPP1 and
SOX9 usually represent cholangiocyte-like cell markers (47, 48),
they have been shown to be also expressed in de-differentiated
mature hepatocytes upon on injury by 3,5-diethoxycarbonyl-1,4-
dihydrocollidine (DDC) (49). Furthermore, a de-differentiated
SPP1/SOX9-positive hepatocyte population has been described
in DDC-injured livers, which can be found near Epcam-
positive expanding DR cells (50). Upregulation of Afp in
the IMP2-2 livers (51) further suggests a de-differentiation
process (52). Moreover, AFP expression was associated with
EPCAM and PROM1 expression in BEX1-acclerated liver injury
in the choline-deficient, ethionine-supplemented (CDE) diet
model (53).
Interestingly, IMP2-2 tg mice showed significantly elevated
levels of Cdh1, which is an epithelial marker overexpressed in
LPCs. CDH1 expression can enhance maintenance of embryonic
stem cell pluripotency [reviewed in (54)] and progressively
increases with elevated numbers of progenitor cells (55).
CDH1 expressing cells probably overlap with cells positive
for DLK1 (56), which is also induced in IMP2-2 tg livers
(28). In the fetal liver, DLK1 is specific for AFP-positive
hepatoblasts (57). As the biliary markers Krt19 and Sox9 were
not altered in IMP2-2 tg mice on normal chow, IMP2-2 tg
mice seem to have an increased amount of de-differentiated
hepatocyte-like cells (58). Still, as DLK1-positive progenitor
cells are bipotential progenitor cells (59), they might also be
the source of the accelerated occurrence of KRT19-positive
DR cells observed on MCD feeding in IMP2-2 tg animals
with significantly increased levels of both biliary markers
Sox9 and Krt19. After partial hepatectomy proliferation of a
specific subpopulation of cells positive for KRT19, AFP, and
DLK1 has been described (58). Taken together, the MCD
diet seems to provoke DR in IMP2-2 tg mice, which is
characterized by a mixed cell population of a de-differentiated or
undifferentiated phenotype.
Expression of SPP1 is associated with severe NASH in
humans (60). SPP1 expression has been shown to be regulated
by promoter methylation in liver fibrosis (41). Methylation
changes of the SPP1 gene differed between human HCC and
our IMP2-2 mouse model. Only single CpG sites were altered
regarding methylation. CpG#1, which was hypomethylated in
the IMP2-2 tg mice, is located within the binding site of runt-
related transcription factor 2 (Runx2) in the Spp1 promoter.
Interestingly, reduced methylation of CpG#1 of the human
SPP1 promoter was reported to influence transcription factor
binding in SH-SY5Y bone marrow cells, thereby leading to
increased SPP1 expression (61) suggesting a similar mechanism
for IMP2-2 induced Spp1 expression. SPP1 is able to activate
HSCs leading to ECM production (62, 63) thereby promoting
fibrosis. Immunohistochemical stainings of IMP2-2 tg livers of
MCD-fed mice revealed a morphologically mixed type of DR
cells in small nests and in bile duct-like formations. More
precisely, ECM deposition and activation of matrix-producing
cells occurred in front of proliferating DR cells as it has been
described for the CDE model (55). Also progenitor cells positive
for DLK1 were reported to be surrounded by a laminin layer
in the rat liver (58). The laminin and hyaluronic acid staining
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pattern in IMP2-2 tg livers supports the hypothesis that the
DR cell compartments are surrounded and supported by an
ECM layer (55).
The shortened survival in IMP2-2 tg mice in MCD-DEN
regime shows that IMP2-2 increases liver damage in chronic
liver disease. The IMP2-2 transgenic mice were more susceptible
toward DR and fibrosis caused by the MCD diet alone, since DR
was already observed after 2 weeks of feeding. The difference
between the genotypes was even more pronounced after 4
weeks, but became similar between IMP2-2 transgenic and wt
mice after 12 weeks. This is explained by the fact that 12
weeks of MCD diet are generally accepted to be sufficient for
induction of DR and fibrosis in wild-type mice (18). Therefore,
the increased susceptibility of the IMP2-2 tg mice is probably
masked by the advanced diet-induced liver disease in the
latest analyzed time point of 12 weeks. With an additional
challenge, such as DEN, IMP2-2 tg livers were again more
susceptible. In fact, cirrhosis only occurred in IMP2-2 tg livers,
which is probably due to the triggered progression of fibrosis
by IMP2-2 (21).
Taken together, hepatic IMP2-2 expression leads to a
de-differentiated cell population and enhanced DR, which
promotes the development of cirrhosis in the MCD mouse
model. Concordantly, also human cirrhotic samples expressed
high IMP2 levels suggesting a similar role for IMP2 in
human cirrhosis.
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